Global Opioid Induced Constipation (OIC) Drugs Market Research Report 2018
- QYR2809699
- 129 Pages
- November 2018
- Pharmaceuticals
This report studies the global Opioid Induced Constipation (OIC) Drugs market status and forecast, categorizes the global Opioid Induced Constipation (OIC) Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
The major manufacturers covered in this report
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The study objectives of this report are:
To analyze and study the global Opioid Induced Constipation (OIC) Drugs capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Opioid Induced Constipation (OIC) Drugs manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Opioid Induced Constipation (OIC) Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Opioid Induced Constipation (OIC) Drugs Manufacturers
Opioid Induced Constipation (OIC) Drugs Distributors/Traders/Wholesalers
Opioid Induced Constipation (OIC) Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Opioid Induced Constipation (OIC) Drugs market, by end-use.
Detailed analysis and profiles of additional market players.
Global Opioid Induced Constipation (OIC) Drugs Market Research Report 2018
1 Opioid Induced Constipation (OIC) Drugs Market Overview
1.1 Product Overview and Scope of Opioid Induced Constipation (OIC) Drugs
1.2 Opioid Induced Constipation (OIC) Drugs Segment by Type (Product Category)
1.2.1 Global Opioid Induced Constipation (OIC) Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Opioid Induced Constipation (OIC) Drugs Production Market Share by Type (Product Category) in 2017
1.2.3 Lubiprostone
1.2.4 Methyl Naltrexone Bromide
1.2.5 Naldemedine
1.2.6 Alvimopan
Other
1.4 Global Opioid Induced Constipation (OIC) Drugs Segment by Application
1.4.1 Opioid Induced Constipation (OIC) Drugs Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.5 Global Opioid Induced Constipation (OIC) Drugs Market by Region (2013-2025)
1.5.1 Global Opioid Induced Constipation (OIC) Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.5.2 North America Status and Prospect (2013-2025)
1.5.3 Europe Status and Prospect (2013-2025)
1.5.4 China Status and Prospect (2013-2025)
1.5.5 Japan Status and Prospect (2013-2025)
1.5.6 Southeast Asia Status and Prospect (2013-2025)
1.5.7 India Status and Prospect (2013-2025)
1.6 Global Market Size (Value) of Opioid Induced Constipation (OIC) Drugs (2013-2025)
1.6.1 Global Opioid Induced Constipation (OIC) Drugs Revenue Status and Outlook (2013-2025)
1.6.2 Global Opioid Induced Constipation (OIC) Drugs Capacity, Production Status and Outlook (2013-2025)
2 Global Opioid Induced Constipation (OIC) Drugs Market Competition by Manufacturers
2.1 Global Opioid Induced Constipation (OIC) Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Opioid Induced Constipation (OIC) Drugs Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Opioid Induced Constipation (OIC) Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Opioid Induced Constipation (OIC) Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Opioid Induced Constipation (OIC) Drugs Market Competitive Situation and Trends
2.5.1 Opioid Induced Constipation (OIC) Drugs Market Concentration Rate
2.5.2 Opioid Induced Constipation (OIC) Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Opioid Induced Constipation (OIC) Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Opioid Induced Constipation (OIC) Drugs Production and Market Share by Region (2013-2018)
3.3 Global Opioid Induced Constipation (OIC) Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Opioid Induced Constipation (OIC) Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Opioid Induced Constipation (OIC) Drugs Consumption by Region (2013-2018)
4.2 North America Opioid Induced Constipation (OIC) Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Opioid Induced Constipation (OIC) Drugs Production, Consumption, Export, Import (2013-2018)
4.4 China Opioid Induced Constipation (OIC) Drugs Production, Consumption, Export, Import (2013-2018)
4.5 Japan Opioid Induced Constipation (OIC) Drugs Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Opioid Induced Constipation (OIC) Drugs Production, Consumption, Export, Import (2013-2018)
4.7 India Opioid Induced Constipation (OIC) Drugs Production, Consumption, Export, Import (2013-2018)
5 Global Opioid Induced Constipation (OIC) Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Opioid Induced Constipation (OIC) Drugs Production and Market Share by Type (2013-2018)
5.2 Global Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Opioid Induced Constipation (OIC) Drugs Price by Type (2013-2018)
5.4 Global Opioid Induced Constipation (OIC) Drugs Production Growth by Type (2013-2018)
6 Global Opioid Induced Constipation (OIC) Drugs Market Analysis by Application
6.1 Global Opioid Induced Constipation (OIC) Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Opioid Induced Constipation (OIC) Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Opioid Induced Constipation (OIC) Drugs Manufacturers Profiles/Analysis
7.1 Ironwood Pharmaceuticals Inc
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Daiichi Sankyo Co Ltd
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Pfizer
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Progenics Pharmaceuticals Inc
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Shionogi & Co., Ltd
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Allergan Plc
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Nektar Therapeutics
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Purdue Pharma
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 S.L.A. Pharma AG
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.8 Mundipharma International Limited
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 Ono Pharmaceutical Co., Ltd
7.12 Takeda Pharmaceutical Company Limited
7.13 Theravance Biopharma Inc
7.14 Valeant Pharmaceuticals International
7.15 Cosmo Pharmaceuticals SA
7.16 Daewoong Pharmaceutical
7.17 C.B. Fleet Company
7.18 Sucampo Pharmaceuticals
8 Opioid Induced Constipation (OIC) Drugs Manufacturing Cost Analysis
8.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Opioid Induced Constipation (OIC) Drugs Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Opioid Induced Constipation (OIC) Drugs Market Forecast (2018-2025)
12.1 Global Opioid Induced Constipation (OIC) Drugs Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Opioid Induced Constipation (OIC) Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Opioid Induced Constipation (OIC) Drugs Price and Trend Forecast (2018-2025)
12.2 Global Opioid Induced Constipation (OIC) Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Opioid Induced Constipation (OIC) Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Opioid Induced Constipation (OIC) Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Opioid Induced Constipation (OIC) Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Opioid Induced Constipation (OIC) Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Opioid Induced Constipation (OIC) Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Opioid Induced Constipation (OIC) Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Opioid Induced Constipation (OIC) Drugs Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Opioid Induced Constipation (OIC) Drugs Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
Figure Picture of Opioid Induced Constipation (OIC) Drugs
Figure Global Opioid Induced Constipation (OIC) Drugs Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Opioid Induced Constipation (OIC) Drugs Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Lubiprostone
Table Major Manufacturers of Lubiprostone
Figure Product Picture of Methyl Naltrexone Bromide
Table Major Manufacturers of Methyl Naltrexone Bromide
Figure Product Picture of Naldemedine
Table Major Manufacturers of Naldemedine
Figure Product Picture of Alvimopan
Table Major Manufacturers of Alvimopan
Figure Product Picture of Other
Table Major Manufacturers of Other
Figure Global Opioid Induced Constipation (OIC) Drugs Consumption (K Pcs) by Applications (2013-2025)
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Global Opioid Induced Constipation (OIC) Drugs Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2013-2025)
Figure North America Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs) Status and Outlook (2013-2025)
Figure Global Opioid Induced Constipation (OIC) Drugs Major Players Product Capacity (K Pcs) (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Capacity (K Pcs) of Key Manufacturers (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Opioid Induced Constipation (OIC) Drugs Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Opioid Induced Constipation (OIC) Drugs Capacity (K Pcs) of Key Manufacturers in 2018
Figure Global Opioid Induced Constipation (OIC) Drugs Major Players Product Production (K Pcs) (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Production (K Pcs) of Key Manufacturers (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Production Share by Manufacturers (2013-2018)
Figure 2017 Opioid Induced Constipation (OIC) Drugs Production Share by Manufacturers
Figure 2017 Opioid Induced Constipation (OIC) Drugs Production Share by Manufacturers
Figure Global Opioid Induced Constipation (OIC) Drugs Major Players Product Revenue (Million USD) (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers
Table 2018 Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers
Table Global Market Opioid Induced Constipation (OIC) Drugs Average Price (USD/Pcs) of Key Manufacturers (2013-2018)
Figure Global Market Opioid Induced Constipation (OIC) Drugs Average Price (USD/Pcs) of Key Manufacturers in 2017
Table Manufacturers Opioid Induced Constipation (OIC) Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Opioid Induced Constipation (OIC) Drugs Product Category
Figure Opioid Induced Constipation (OIC) Drugs Market Share of Top 3 Manufacturers
Figure Opioid Induced Constipation (OIC) Drugs Market Share of Top 5 Manufacturers
Table Global Opioid Induced Constipation (OIC) Drugs Capacity (K Pcs) by Region (2013-2018)
Figure Global Opioid Induced Constipation (OIC) Drugs Capacity Market Share by Region (2013-2018)
Figure Global Opioid Induced Constipation (OIC) Drugs Capacity Market Share by Region (2013-2018)
Figure 2017 Global Opioid Induced Constipation (OIC) Drugs Capacity Market Share by Region
Table Global Opioid Induced Constipation (OIC) Drugs Production by Region (2013-2018)
Figure Global Opioid Induced Constipation (OIC) Drugs Production (K Pcs) by Region (2013-2018)
Figure Global Opioid Induced Constipation (OIC) Drugs Production Market Share by Region (2013-2018)
Figure 2017 Global Opioid Induced Constipation (OIC) Drugs Production Market Share by Region
Table Global Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) by Region (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2013-2018)
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2013-2018)
Table 2017 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region
Figure Global Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs) and Growth Rate (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table North America Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Europe Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table China Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Japan Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Southeast Asia Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table India Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption (K Pcs) Market by Region (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Market Share by Region (2013-2018)
Figure Global Opioid Induced Constipation (OIC) Drugs Consumption Market Share by Region (2013-2018)
Figure 2017 Global Opioid Induced Constipation (OIC) Drugs Consumption (K Pcs) Market Share by Region
Table North America Opioid Induced Constipation (OIC) Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Europe Opioid Induced Constipation (OIC) Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table China Opioid Induced Constipation (OIC) Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Japan Opioid Induced Constipation (OIC) Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Southeast Asia Opioid Induced Constipation (OIC) Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table India Opioid Induced Constipation (OIC) Drugs Production, Consumption, Import & Export (K Pcs) (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Production (K Pcs) by Type (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Production Share by Type (2013-2018)
Figure Production Market Share of Opioid Induced Constipation (OIC) Drugs by Type (2013-2018)
Figure 2017 Production Market Share of Opioid Induced Constipation (OIC) Drugs by Type
Table Global Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Opioid Induced Constipation (OIC) Drugs by Type (2013-2018)
Figure 2017 Revenue Market Share of Opioid Induced Constipation (OIC) Drugs by Type
Table Global Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs) by Type (2013-2018)
Figure Global Opioid Induced Constipation (OIC) Drugs Production Growth by Type (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption (K Pcs) by Application (2013-2018)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Market Share by Application (2013-2018)
Figure Global Opioid Induced Constipation (OIC) Drugs Consumption Market Share by Applications (2013-2018)
Figure Global Opioid Induced Constipation (OIC) Drugs Consumption Market Share by Application in 2017
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Growth Rate by Application (2013-2018)
Figure Global Opioid Induced Constipation (OIC) Drugs Consumption Growth Rate by Application (2013-2018)
Table Ironwood Pharmaceuticals Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Production Growth Rate (2013-2018)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Production Market Share (2013-2018)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Revenue Market Share (2013-2018)
Table Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Production Growth Rate (2013-2018)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Production Market Share (2013-2018)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Revenue Market Share (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Production Growth Rate (2013-2018)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Production Market Share (2013-2018)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Revenue Market Share (2013-2018)
Table Progenics Pharmaceuticals Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Production Growth Rate (2013-2018)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Production Market Share (2013-2018)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Revenue Market Share (2013-2018)
Table Shionogi & Co., Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Production Growth Rate (2013-2018)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Production Market Share (2013-2018)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Revenue Market Share (2013-2018)
Table Allergan Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Production Growth Rate (2013-2018)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Production Market Share (2013-2018)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Revenue Market Share (2013-2018)
Table Nektar Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Production Growth Rate (2013-2018)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Production Market Share (2013-2018)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Revenue Market Share (2013-2018)
Table Purdue Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Production Growth Rate (2013-2018)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Production Market Share (2013-2018)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Revenue Market Share (2013-2018)
Table S.L.A. Pharma AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Production Growth Rate (2013-2018)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Production Market Share (2013-2018)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Revenue Market Share (2013-2018)
Table Mundipharma International Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Production Growth Rate (2013-2018)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Production Market Share (2013-2018)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid Induced Constipation (OIC) Drugs
Figure Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
Figure Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Opioid Induced Constipation (OIC) Drugs Major Manufacturers in 2017
Table Major Buyers of Opioid Induced Constipation (OIC) Drugs
Table Distributors/Traders List
Figure Global Opioid Induced Constipation (OIC) Drugs Capacity, Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Opioid Induced Constipation (OIC) Drugs Price (Million USD) and Trend Forecast (2018-2025)
Table Global Opioid Induced Constipation (OIC) Drugs Production (K Pcs) Forecast by Region (2018-2025)
Figure Global Opioid Induced Constipation (OIC) Drugs Production Market Share Forecast by Region (2018-2025)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption (K Pcs) Forecast by Region (2018-2025)
Figure Global Opioid Induced Constipation (OIC) Drugs Consumption Market Share Forecast by Region (2018-2025)
Figure North America Opioid Induced Constipation (OIC) Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure North America Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Opioid Induced Constipation (OIC) Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Opioid Induced Constipation (OIC) Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Europe Opioid Induced Constipation (OIC) Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Opioid Induced Constipation (OIC) Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Central & South America Opioid Induced Constipation (OIC) Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Central & South America Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Central & South America Opioid Induced Constipation (OIC) Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Opioid Induced Constipation (OIC) Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Figure India Opioid Induced Constipation (OIC) Drugs Production (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Opioid Induced Constipation (OIC) Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025)
Table Global Opioid Induced Constipation (OIC) Drugs Production (K Pcs) Forecast by Type (2018-2025)
Figure Global Opioid Induced Constipation (OIC) Drugs Production (K Pcs) Forecast by Type (2018-2025)
Table Global Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Opioid Induced Constipation (OIC) Drugs Price Forecast by Type (2018-2025)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption (K Pcs) Forecast by Application (2018-2025)
Figure Global Opioid Induced Constipation (OIC) Drugs Consumption (K Pcs) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
